CELZ vs GILD · $8.3M cap vs P/E 18, rev $7.80B
Creative Medical Technology Holdings Inc (CELZ) versus Gilead Sciences Inc (GILD) — a side-by-side from cached financials, not a winner call.
Creative Medical Technology Holdings Inc (CELZ) is a biotechnology company listed on NASDAQ.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US. It is led by Daniel P. O'Day.
Latest reported CELZ revenue for 2026-06-30 was $0. Net income was -$2.9M. CELZ currently screens at market cap $8.3M.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
CELZ currently screens at market cap $8.3M. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Not investment advice. Open the CELZ and GILD stock pages for the full models.
Not investment advice.